UZH-Logo

Maintenance Infos

Browse by Creators - Zurich Open Repository and Archive

Navigate back| Up a level
Export as
Number of items: 21.

Lütolf, U M (2012). Die Radio-Onkologie - eine wichtige Säule in der Krebstherapie. In: Kantonsspital Winterthur. 100 Jahre Strahlentherapie - Strahlen fürs Leben. Winterthur: Kantonsspital Winterthur, 44-45.

Lütolf, U M (2012). Manifest "Medizin gegen Spital-Bürokratie". Schweizerische Ärztezeitung, 93(4):107-108.

Oehler, C; Frei, K; Rushin, E J; McSheehy, P M J; Weber, D; Allegrini, P R; Weniger, D; Lütolf, U M; Knuth, A; Yonekawa, Y; Barath, K; Broggini-Tenzer, A; Pruschy, M; Hofer, S (2012). Patupilone (Epothilone B) for recurrent glioblastoma: Clinical outcome and translational analysis of a single-institution phase I/II trial. Oncology, 83(1):1-9.

Linsenmeier, C; Ackermann, C; Nater, H; Vögeli, S; Lütolf, U M (2011). Mit weniger Therapiesitzungen sicher und effizienter ans Ziel. Leading Opinions. Hämatologie & Onkologie, 7(4):84-86.

Lohse, I; Lang, S; Hrbacek, J; Scheidegger, S; Bodis, S; Macedo, N; Feng, J; Lütolf, U M; Zaugg, K (2011). Effect of high dose per pulse flattening filter-free beams on cancer cell survival. Radiotherapy and Oncology, 101(1):226-232.

Studer, G; Glanzmann, C; Studer, S P; Grätz, K W; Bredell, M; Locher, M C; Lütolf, U M; Zwahlen, R A (2011). Risk-adapted dental care prior to intensity-modulated radiotherapy (IMRT). Schweizer Monatsschrift für Zahnmedizin SMfZ, 121(3):216-229.

Oehler, C; Provencher, S; Donath, D; Bahary, J P; Lütolf, U M; Ciernik, I F (2010). Chemo-radiation with or without mandatory split in anal carcinoma: experiences of two institutions and review of the literature. Radiation Oncology, 5:36.

Probst-Hensch, N M; Steiner, J H B; Schraml, P; Varga, Z; Zürrer-Härdi, U; Storz, M; Korol, D; Fehr, M K; Fink, D; Pestalozzi, B C; Lütolf, U M; Theurillat, J P; Moch, H (2010). IGFBP2 and IGFBP3 protein expressions in human breast cancer: association with hormonal factors and obesity. Clinical Cancer Research, 16(3):1025-1032.

Linsenmeier, C; Thoennessen, D; Negretti, L; Bourquin, J P; Streller, T; Lütolf, U M; Oertel, S (2010). Total body irradiation (TBI) in pediatric patients. A single-center experience after 30 years of low-dose rate irradiation. Strahlentherapie und Onkologie, 186(11):614-620.

Rothschild, S; Dolder, M; Seifert, Burkhardt; Lütolf, U M; Ciernik, I F (2009). Radiation therapy for HIV-associated diffuse large cell non-Hodgkin lymphoma. Journal of the International Association of Physicians in AIDS Care, 8(4):239-248.

Kita, D; Ciernik, I F; Vaccarella, S; Franceschi, S; Kleihues, P; Lütolf, U M; Ohgaki, H (2009). Age as a predictive factor in glioblastomas: population-based study. Neuroepidemiology, 33(1):17-22.

Rothschild, S; Ciernik, I F; Hartmann, M; Schuknecht, B; Lütolf, U M; Huber, A M (2009). Cholesteatoma triggering squamous cell carcinoma: case report and literature review of a rare tumor. American Journal of Otolaryngology, 30(4):256-260.

Oertel, S; Schneider, U; Keel, M; Lütolf, U M; Bosshard, G (2008). Prophylaxis of heterotopic ossification in patients sedated after polytrauma: medical and ethical considerations. Strahlentherapie und Onkologie, 184(4):212-217.

Oehler-Jänne, C; Taverna, C; Stanek, N; Negretti, L; Lütolf, U M; Ciernik, I F (2008). Consolidative involved field radiotherapy after high dose chemotherapy and autologous stem cell transplantation for non-Hodgkin's lymphoma: a case-control study. Hematological Oncology, 26(2):82-90.

Weder, D; Lütolf, U M (2008). Radiotherapie. In: Petru, E. Praxisbuch Gynäkologische Onkologie. Heidelberg: Springer, 223-230.

Studer, G; Glanzmann, C; Studer, S P; Grätz, K W; Lütolf, U M; Zwahlen, R A (2007). Empfehlung für die Zahnsanierung vor intensitätsmodulierter Radiotherapie (IMRT). UniversitätsSpital Zürich (USZ)-Richtlinien-Anpassung. Schweizer Monatsschrift für Zahnmedizin SMfZ, 117(6):637-647.

Oehler-Jänne, C; Seifert, Burkhardt; Lütolf, U M; Studer, G; Glanzmann, C; Ciernik, I F (2007). Clinical outcome after treatment with a brachytherapy boost versus external beam boost for anal carcinoma. Brachytherapy, 6(3):218-226.

Oehler-Jänne, C; Seifert, Burkhardt; Lütolf, U M; Ciernik, I F (2006). Local tumor control and toxicity in HIV-associated anal carcinoma treated with radiotherapy in the era of antiretroviral therapy. Radiation Oncology, 1(29):1-9.

Studer, G; Huguenin, P U; Davis, J B; Kunz, G; Lütolf, U M; Glanzmann, C (2006). IMRT using simultaneously integrated boost (SIB) in head and neck cancer patients. Radiation Oncology, 1:7.

Ohgaki, H; Dessen, P; Jourde, B; Horstmann, S; Nishikawa, T; Di Patre, P L; Burkhard, C; Schüler, D; Probst-Hensch, N M; Maiorka, P C; Baeza, N; Pisani, P; Yonekawa, Y; Yasargil, M G; Lütolf, U M; Kleihues, P (2004). Genetic pathways to glioblastoma: a population-based study. Cancer Research, 64(19):6892-6899.

Okamoto, Y; Di Patre, P L; Burkhard, C; Horstmann, S; Jourde, B; Fahey, M; Schüler, D; Probst-Hensch, N M; Yasargil, M G; Yonekawa, Y; Lütolf, U M; Kleihues, P; Ohgaki, H (2004). Population-based study on incidence, survival rates, and genetic alterations of low-grade diffuse astrocytomas and oligodendrogliomas. Acta Neuropathologica, 108(1):49-56.

This list was generated on Fri Jul 21 16:24:52 2017 CEST.